Indiana University Philanthropic Venture Fund - aVenture Fund Research
2017
Indiana University Philanthropic Venture Fund
The Indiana University Philanthropic Venture Fund, established in 2017, focuses on bridging the startup funding gap by making equity investments in high-potential early-stage companies with ties to Indiana University. The fund typically invests in pre-seed, seed, and Series A rounds, supporting innovative ventures that align with the university's mission to foster a prosperous and innovative Indiana.
Notable portfolio companies include Amplified Sciences, Confluence Pharmaceuticals, Encamp, MBX Biosciences, Mentor Collective, Openinsights, The Bee Corp, Vascugen, and Ziptility. Managed by the IU Research and Technology Corporation (IURTC), the fund leverages its deep connections within the IU ecosystem to provide unique value-add services such as mentorship, strategic guidance, and access to a robust network of industry experts and alumni.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies9
Follow-on Investments1
Current Portfolio Count9
Top Investment Stages
Pre-Seed4 (50.0%)
Seed2 (25.0%)
Angel1 (12.5%)
Series A1 (12.5%)
Stage Mix
Pre-Seed 50%Seed 25%Angel 13%Series A 13%
Concentration shown as share of disclosed investments by stage.
